🔎 Trials Near Me

Početna › Rak vrata maternice › Florida

Kliničke studije za Rak vrata maternice u državi Florida

29 studija za Rak vrata maternice traži sudionike na lokacijama u državi Florida.

Gradovi u državi Florida

Službeni tekst studije (engleski)

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06760819

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06172478

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • Mayo Clinic, Jacksonville
  • Genoma Research, Inc., Miami
  • Orlando Health, Orlando
  • i još 1
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Žene · Ažurirano 29. ruj 2026. · NCT05051722

DESTINY-PANTUMOUR04

  • Research Site, Coral Springs
  • Research Site, St. Petersburg
  • Research Site, West Palm Beach
U tijeku regrutacijaOpažajna studija
Od 18 do 130 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07124000

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

  • Mount Sinai Comprehensive Cancer Center - Aventura, Aventura
  • Florida Cancer Specialists, Bonita Springs
  • Florida Cancer Specialists, Bradenton
  • i još 27
U tijeku regrutacijaFaza 4
Od 18 godina i više · Žene · Ažurirano 25. ruj 2026. · NCT06952660

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  • Florida Cancer Specialists - South ( Site 7001), Fort Myers
  • Mount Sinai Braman Comprehensive Cancer Center ( Site 5043), Miami Beach
  • Mount Sinai Comprehensive Cancer Center ( Site 6000), Miami Beach
  • i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Žene · Ažurirano 25. ruj 2026. · NCT07216703

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • MDR Core Network, Boynton Beach
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06047379

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Sylvester Comprehensive Cancer Center, Miami
  • Sara Cannon Research Institute Lake Nona, Orlando
  • Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT05983432

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • Florida Cancer Specialists - Lake Nona, Orlando
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT07109726

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • University of Miami, Miami
  • Sarah Cannon Research Institute - Lake Nona Florida, Orlando
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 10. ruj 2026. · NCT06293898

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

  • SCRI FCS Sarasota, Sarasota
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 27. kol 2026. · NCT07227168

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

  • Mayo Clinic in Florida, Jacksonville
U tijeku regrutacijaFaza 1/2
Od 16 godina i više · Oba spola · Ažurirano 20. kol 2026. · NCT05269381

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • AdventHealth Celebration, Celebration
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT05592626

Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions.

  • UF Health Internal Medicine, Gainesville
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 25 godina i više · Žene · Ažurirano 10. kol 2026. · NCT07351110

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

  • Ascension Medical Group St. Vincent's Obstetrics and Gynecology, Jacksonville
  • Mercy Hospital, Miami
  • South Miami Hospital, Miami
  • i još 4
U tijeku regrutacija
Od 18 godina i više · Žene · Ažurirano 30. srp 2026. · NCT04831580

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 7. srp 2026. · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • American Oncology Partners, PA. a Florida professional service corporation, d/b/a Vista Oncology, Fort Myers
  • Florida Cancer Specialists & Research Institute, LLC, Fort Myers
  • Memorial Cancer Institute, Hollywood
  • i još 4
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 6. srp 2026. · NCT04389632

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 6. svi 2026. · NCT06239194

A Study of VET3-TGI in Patients With Solid Tumors

  • University of Miami, Miami
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 7. tra 2026. · NCT06444815

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

  • Mayo Clinic in Florida, Jacksonville
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 12. ožu 2026. · NCT06349642

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

  • University of Florida, Gainesville
U tijeku regrutacijaOpažajna studija
Od 18 do 89 godina · Žene · Ažurirano 12. velj 2026. · NCT07214584

A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

  • Florida Cancer Specialists (from Sarah Canon research Institute), Orlando
  • Tampa General Hospital, Tampa
  • Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 2. velj 2026. · NCT06319963

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Miami Cancer Institute, Miami
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 godina i više · Oba spola · Ažurirano 20. sij 2026. · NCT05366881

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

  • Dren Investigational Site, Orlando
  • Dren Investigational Site, Sarasota
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 7. sij 2026. · NCT06999187

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 118, Celebration
  • Research Site 127, Margate
  • Research Site 137, Orlando
  • i još 2
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 21. stu 2025. · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Jacksonville
  • Massive Bio SYNERGY-AI site, Miami
  • Massive Bio SYNERGY-AI site, Tampa
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774

A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

  • AdventHealth, Orlando
U tijeku regrutacijaFaza 2
Od 18 do 99 godina · Žene · Ažurirano 22. lis 2025. · NCT05512208

A Beta-only IL-2 ImmunoTherapY Study

  • Boca Raton Regional Hospital, Boca Raton
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 9. srp 2025. · NCT05086692

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.